{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:41:02Z","timestamp":1758638462760,"version":"3.44.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"CNS"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.toxicon.2020.02.004","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T11:33:11Z","timestamp":1581075191000},"page":"46-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["What clinicians and patients want: The past, the presence, and the future of the botulinum toxins"],"prefix":"10.1016","volume":"177","author":[{"given":"Anatol","family":"Kivi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songjin","family":"Ri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f6rg","family":"Wissel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2020.02.004_bib1","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1113\/jphysiol.2012.242131","article-title":"Transsynaptic inhibition of spinal transmission by A2 botulinum toxin","volume":"591","author":"Akaike","year":"2013","journal-title":"J Physiol"},{"key":"10.1016\/j.toxicon.2020.02.004_bib2","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1212\/WNL.0000000000006688","article-title":"High prevalence of neutralizing antibodies after long-term botulinum neurotoxin therapy","volume":"92","author":"Albrecht","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2020.02.004_bib3","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1044\/1092-4388(2006\/081)","article-title":"Alterations in CNS activity induced by botulinum toxin treatment in spasmodic dysphonia: an H215O PET study","volume":"49","author":"Ali","year":"2006","journal-title":"J. Speech Lang. Hear. Res."},{"key":"10.1016\/j.toxicon.2020.02.004_bib4","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin A","volume":"28","author":"Antonucci","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.toxicon.2020.02.004_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3111\/13696998.2014.925462","article-title":"Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians)","volume":"17","author":"Bensmail","year":"2014","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.toxicon.2020.02.004_bib6","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.celrep.2016.06.104","article-title":"Interneuronal transfer and distal action of tetanus toxin and botulinum neurotoxins A and D in central neurons","volume":"16","author":"Bomba-Warczak","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.toxicon.2020.02.004_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1113\/jphysiol.1949.sp004364","article-title":"The action of botulinum toxin on the neuro-muscular junction","volume":"109","author":"Burgen","year":"1949","journal-title":"J Physiol"},{"key":"10.1016\/j.toxicon.2020.02.004_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/PRS.0b013e3181904c31","article-title":"Prevention of anastomotic thrombosis by botulinum toxin a in an animal model","volume":"123","author":"Clemens","year":"2009","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.toxicon.2020.02.004_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2011.05.041","article-title":"U.S. XEOMIN cervical dystonia study group","volume":"308","author":"Comella","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.toxicon.2020.02.004_bib10","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/WNL.42.4.878","article-title":"Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance","volume":"42","author":"Comella","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2020.02.004_bib11","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1212\/01.wnl.0000345010.98495.fc","article-title":"Do the unintended actions of botulinum toxin at distant sites have clinical implications?","volume":"72","author":"Curr\u00e0","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2020.02.004_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/infdis\/jit450","article-title":"Molecular characterization of a novel botulinum neurotoxin type H gene","volume":"209","author":"Dover","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.toxicon.2020.02.004_bib13","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/mds.23497","article-title":"Botulinum toxin modulates basal ganglia but not deficient somatosensory activation in orofacial dystonia","volume":"26","author":"Dresel","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2020.02.004_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/brain\/awh665","article-title":"Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia","volume":"129","author":"Dresel","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.toxicon.2020.02.004_bib15","first-page":"CD004314","article-title":"Botulinum toxin type A versus botulinum toxin type B for cervical dystonia","volume":"10","author":"Duarte","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"year":"2007","author":"Dubowitz","series-title":"Muscle Biopsy: A Practical Approach","key":"10.1016\/j.toxicon.2020.02.004_bib16"},{"key":"10.1016\/j.toxicon.2020.02.004_bib17","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00702-013-1048-3","article-title":"A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin\u00ae) in cervical dystonia","volume":"120","author":"Evidente","year":"2013","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.toxicon.2020.02.004_bib18","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12640-015-9565-5","article-title":"Neutralizing antibody and botulinum toxin therapy: a systematic review and meta-analysis","volume":"29","author":"Fabbri","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.toxicon.2020.02.004_bib19","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.3390\/toxins10120535","article-title":"AbobotulinumtoxinA (Dysport\u00ae), OnabotulinumtoxinA (Botox\u00ae), and IncobotulinumtoxinA (Xeomin\u00ae) neurotoxin content and potential implications for duration of response in patients","volume":"10","author":"Field","year":"2018","journal-title":"Toxins"},{"issue":"5","key":"10.1016\/j.toxicon.2020.02.004_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/WNF.0b013e31826248b8","article-title":"Iatrogenic botulism after the therapeutic use of botulinum toxin-A: a case report and review of the literature","volume":"35","author":"Ghasemi","year":"2019","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.toxicon.2020.02.004_bib21","series-title":"Serological Subtypes of Botulinal Neurotoxins","first-page":"421","article-title":"Botulinum and tetanus neurotoxins","author":"Gim\u00e9nez","year":"1993"},{"key":"10.1016\/j.toxicon.2020.02.004_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00115-016-0250-6","article-title":"[Use of intracutaneous or subcutaneous botulinum toxin for postherpetic neuralgia]","volume":"88","author":"Halb","year":"2017","journal-title":"Nervenarzt"},{"key":"10.1016\/j.toxicon.2020.02.004_bib23","first-page":"94","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of movement disorder","volume":"67","author":"Hallett","year":"2013"},{"key":"10.1016\/j.toxicon.2020.02.004_bib24","first-page":"719","article-title":"Potency equivalence of botulinum toxin preparations","volume":"87","author":"Hambleton","year":"1994","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.toxicon.2020.02.004_bib25","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/s00415-016-8050-2","article-title":"A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia","volume":"263","author":"Han","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.toxicon.2020.02.004_bib26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jnnp.68.6.689","article-title":"Botulinum toxin in muscle spasticity","volume":"68","author":"Hardie","year":"2000","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.toxicon.2020.02.004_bib27","series-title":"Topley and Wilson's Microbiology and Microbial Infections","first-page":"731","article-title":"Clostridium: the spore-bearing anaerobes","author":"Hatheway","year":"1998"},{"key":"10.1016\/j.toxicon.2020.02.004_bib28","first-page":"642","article-title":"Comparison of surface and ultrasound localization to identify forearm flexor muscles for botulinum toxin injections","volume":"2","author":"Henzel","year":"2010","journal-title":"Pharm. Manag. PM R"},{"key":"10.1016\/j.toxicon.2020.02.004_bib29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/mus.23409","article-title":"Elimination of dysphagia using ultrasound guidance for botulinum toxin injections in cervical dystonia","volume":"46","author":"Hong","year":"2012","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.toxicon.2020.02.004_bib30","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1177\/1535370219878143","article-title":"Botulinum toxin type A suppresses arterial vasoconstriction by regulating calcium sensitization and the endothelium-dependent endothelial nitric oxide synthase\/soluble guanylyl cyclase\/cyclic guanosine monophosphate pathway: an in vitro study","volume":"244","author":"Hu","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.toxicon.2020.02.004_bib31","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1021\/ac5001509","article-title":"Three enzymatically active neurotoxins of Clostridium botulinum strain Af84: BoNT\/A2,\/F4, and\/F5","volume":"86","author":"Kalb","year":"2014","journal-title":"Anal. Chem."},{"key":"10.1016\/j.toxicon.2020.02.004_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.870130122","article-title":"Change in lateralization of the P22\/N30 cortical component of median nerve somatosensory evoked potentials in patients with cervical dystonia after successful treatment with botulinum toxin A","volume":"13","author":"Kanovsk\u00fd","year":"1998","journal-title":"Mov. Disord."},{"year":"1822","author":"Kerner","series-title":"Das Fettgift oder die Fetts\u00e4ure und ihre Wirkungen auf den thierischen Organismus. Ein Beytrag zur Untersuchung des in verdorbenen W\u00fcrsten giftig wirkenden Stoffes","key":"10.1016\/j.toxicon.2020.02.004_bib33"},{"key":"10.1016\/j.toxicon.2020.02.004_bib34","first-page":"1","article-title":"Vergiftung durch verdorbene W\u00fcrste","volume":"3","author":"Kerner","year":"1817","journal-title":"T\u00fcbinger Bl\u00e4tter Naturwissenschaften Arzneykunde."},{"key":"10.1016\/j.toxicon.2020.02.004_bib35","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/mds.23681","article-title":"Botulinum toxin injections reduce associative plasticity in patients with primary dystonia","volume":"26","author":"Kojovic","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2020.02.004_bib36","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mus.880140711","article-title":"Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes","volume":"14","author":"Lange","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.toxicon.2020.02.004_bib37","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jocn.2018.10.059","article-title":"Electrophysiological abnormalities in iatrogenic botulism: two case reports and review of the literature","volume":"60","author":"Leonardi","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.toxicon.2020.02.004_bib38","series-title":"M. Handbook of Botulinum Toxin Treatment","first-page":"3","article-title":"History and current applications of botulinum toxin treatment","author":"Moore","year":"2003"},{"key":"10.1016\/j.toxicon.2020.02.004_bib39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00702-012-0893-9","article-title":"Immunog enicity of botulinum toxins","volume":"120","author":"Naumann","year":"2013","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.toxicon.2020.02.004_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.toxicon.2012.10.020","article-title":"Evidence-based \u2028review and assessment of botulinum neurotoxin for the treatment of secretory disorders","volume":"67","author":"Naumann","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2020.02.004_bib41","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/00207454.2011.623807","article-title":"Somatosensory cortical activation in cervical dystonia and its modulation with botulinum toxin: an fMRI study","volume":"122","author":"Opavsk\u00fd","year":"2012","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.toxicon.2020.02.004_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jns.2011.03.040","article-title":"Sensorimotor network in cervical dystonia and the effect of botulinum toxin treatment: a functional MRI study","volume":"306","author":"Opavsk\u00fd","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.toxicon.2020.02.004_bib43","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1310\/tsr21S1-S8","article-title":"Efficacy of therapeutic ultrasound and transcutaneous electrical nerve stimulation compared with botulinum toxin type A in the treatment of spastic equinus in adults with chronic stroke: a pilot randomized controlled trial","volume":"21","author":"Picelli","year":"2014","journal-title":"Top. Stroke Rehabil."},{"key":"10.1016\/j.toxicon.2020.02.004_bib44","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/PHM.0b013e318269d7f3","article-title":"Botulinum toxin type A injection into the gastrocnemius muscle for spastic equinus in adults with stroke: a randomized controlled trial comparing manual needle placement, electrical stimulation and ultrasonography-guided injection techniques","volume":"91","author":"Picelli","year":"2012","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"10.1016\/j.toxicon.2020.02.004_bib45","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.toxicon.2020.02.004_bib46","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/mds.26760","article-title":"Efficacy and safety of abobotulinumtoxinA liquid formulation in cervical dystonia: a randomized-controlled trial","volume":"31","author":"Poewe","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2020.02.004_bib47","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/brain\/118.3.801","article-title":"Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles","volume":"118","author":"Priori","year":"1995","journal-title":"Brain"},{"key":"10.1016\/j.toxicon.2020.02.004_bib48","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/WNF.0b013e31815cba8a","article-title":"Undesirable distant effects following botulinum toxin type a injection","volume":"31","author":"Roche","year":"2008","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.toxicon.2020.02.004_bib49","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nrmicro3295","article-title":"Botulinum neurotoxins: genetic, structural and mechanistic insights","volume":"12","author":"Rossetto","year":"2014","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.toxicon.2020.02.004_bib50","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00702-014-1356-2","article-title":"Relevance of sonography for botulinum toxin treatment of cervical dystonia: an expert statement","volume":"122","author":"Schramm","year":"2015","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.toxicon.2020.02.004_bib51","first-page":"521","article-title":"Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry","volume":"121","author":"Schramm","year":"2014","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.toxicon.2020.02.004_bib52","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"87","author":"Scott","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1016\/j.toxicon.2020.02.004_bib53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1552-6569.2009.00375.x","article-title":"Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study","volume":"20","author":"Senk\u00e1rov\u00e1","year":"2010","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.toxicon.2020.02.004_bib54","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3111\/13696998.2011.653726","article-title":"Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia","volume":"15","author":"Sethi","year":"2012","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.toxicon.2020.02.004_bib55","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/infdis\/43.2.152","article-title":"Studies on Botulinum toxin 3. acid precipitation of botulinus toxin","volume":"43","author":"Snipe","year":"1928","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.toxicon.2020.02.004_bib56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/26412","article-title":"Crystal structure of a SNARE complex involved in synaptic \u2028exocytosis at 2.4 a resolution","volume":"395","author":"Sutton","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.toxicon.2020.02.004_bib57","first-page":"1","article-title":"Novel botulinum neurotoxins: exploring underneath the iceberg tip","volume":"190","author":"Tehran","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.toxicon.2020.02.004_bib58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.mehy.2017.03.011","article-title":"Do flexible inter-injection intervals improve the effects of botulinum toxin A treatment in reducing impairment and disability in patients with spasticity?","volume":"102","author":"Trompetto","year":"2017","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.toxicon.2020.02.004_bib59","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jns.2015.12.049","article-title":"Sensorimotor modulation by botulinum toxin A in post-stroke arm spasticity: passive hand movement","volume":"362","author":"Veverka","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.toxicon.2020.02.004_bib60","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/mds.21759","article-title":"Molding the sensory cortex: spatial acuity improves after botulinum toxin treatment for cervical dystonia","volume":"22","author":"Walsh","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.toxicon.2020.02.004_bib61","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2340\/16501977-1817","article-title":"Functional goal achievement in post-stroke spasticity patients: the BOTOX\u00ae Economic Spasticity Trial (BEST)","volume":"46","author":"Ward","year":"2014","journal-title":"Rehabil. Med."},{"key":"10.1016\/j.toxicon.2020.02.004_bib62","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1212\/WNL.0000000000003789","article-title":"Safety and efficacy of incobotulinumtoxin A doses up to 800 U in limb spasticity: the TOWER study","volume":"88","author":"Wissel","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.toxicon.2020.02.004_bib63","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1388-2457(01)00478-3","article-title":"Remote F-wave changes after local botulinum toxin application","volume":"112","author":"Wohlfarth","year":"2001","journal-title":"Clin. Neurophysiol."}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010120300350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010120300350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:14:02Z","timestamp":1758575642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010120300350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":63,"alternative-id":["S0041010120300350"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2020.02.004","relation":{},"ISSN":["0041-0101"],"issn-type":[{"type":"print","value":"0041-0101"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What clinicians and patients want: The past, the presence, and the future of the botulinum toxins","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2020.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}